 | • レポートコード：MRC2-11QY11369 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は慢性リンパ性白血病（CLL）治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、生物学的療法、その他）市場規模、用途別（病院、クリニック、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別慢性リンパ性白血病（CLL）治療の競争状況、市場シェア ・世界の慢性リンパ性白血病（CLL）治療市場：種類別市場規模 2015年-2020年（化学療法、生物学的療法、その他） ・世界の慢性リンパ性白血病（CLL）治療市場：種類別市場規模予測 2021年-2026年（化学療法、生物学的療法、その他） ・世界の慢性リンパ性白血病（CLL）治療市場：用途別市場規模 2015年-2020年（病院、クリニック、研究所） ・世界の慢性リンパ性白血病（CLL）治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、研究所） ・北米の慢性リンパ性白血病（CLL）治療市場分析：米国、カナダ ・ヨーロッパの慢性リンパ性白血病（CLL）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの慢性リンパ性白血病（CLL）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の慢性リンパ性白血病（CLL）治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの慢性リンパ性白血病（CLL）治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：4SC、AbbVie、ACEA Biosciences、ADC Therapeutics、Aeglea BioTherapeutics、Altor BioScience、Amgen、Aptevo Therapeutics、ArQule、Asana BioSciences、Astellas Pharma、Astex Pharmaceuticals、AstraZeneca、Baliopharm、Bayer、BeiGene、Bellicum Pharmaceuticals、Biogen、Bionomics、Biothera Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of monoclonal disorder and is commonly found in adults in western countries. Based on the severity, patients diagnosed with chronic lymphocytic leukemia die within 2 to 10 years.
Geographically, global relapse Chronic Lymphocytic Leukemia (CLL) treatment market is segmented into North America, Asia Pacific, Europe, and Rest of the World regions. Currently, North America is dominating the global relapse Chronic Lymphocytic Leukemia (CLL) treatment market and is closely followed by Europe. Highly developed healthcare infrastructure, higher healthcare spending, availability of reimbursement policies, higher rates of awareness about relapse Chronic Lymphocytic Leukemia (CLL) and related treatments, availability of highly advanced healthcare tools and higher rates of adoption of new techniques in practice are some of the factors that are driving the Chronic Lymphocytic Leukemia (CLL) treatment market in North America and Europe.
Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Treatment Market
The global Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ 9390.9 million by 2026, from US$ 8411.2 million in 2020, at a CAGR of 10.8%% during 2021-2026.
Global Chronic Lymphocytic Leukemia Treatment Scope and Market Size
Chronic Lymphocytic Leukemia Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Lymphocytic Leukemia Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
4SC
AbbVie
ACEA Biosciences
ADC Therapeutics
Aeglea BioTherapeutics
Altor BioScience
Amgen
Aptevo Therapeutics
ArQule
Asana BioSciences
Astellas Pharma
Astex Pharmaceuticals
AstraZeneca
Baliopharm
Bayer
BeiGene
Bellicum Pharmaceuticals
Biogen
Bionomics
Biothera Pharmaceutical
Market segment by Type, the product can be split into
Chemotherapy
Biological Therapy
Others
Market segment by Application, split into
Hospitals
Clinics
Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Lymphocytic Leukemia Treatment Revenue
1.4 Market by Type
1.4.1 Global Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Biological Therapy
1.4.4 Others
1.5 Market by Application
1.5.1 Global Chronic Lymphocytic Leukemia Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Chronic Lymphocytic Leukemia Treatment Market Perspective (2015-2026)
2.2 Global Chronic Lymphocytic Leukemia Treatment Growth Trends by Regions
2.2.1 Chronic Lymphocytic Leukemia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Lymphocytic Leukemia Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chronic Lymphocytic Leukemia Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Chronic Lymphocytic Leukemia Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chronic Lymphocytic Leukemia Treatment Players by Market Size
3.1.1 Global Top Chronic Lymphocytic Leukemia Treatment Players by Revenue (2015-2020)
3.1.2 Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Chronic Lymphocytic Leukemia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Lymphocytic Leukemia Treatment Market Concentration Ratio
3.2.1 Global Chronic Lymphocytic Leukemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chronic Lymphocytic Leukemia Treatment Revenue in 2019
3.3 Chronic Lymphocytic Leukemia Treatment Key Players Head office and Area Served
3.4 Key Players Chronic Lymphocytic Leukemia Treatment Product Solution and Service
3.5 Date of Enter into Chronic Lymphocytic Leukemia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chronic Lymphocytic Leukemia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
5.2 Global Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chronic Lymphocytic Leukemia Treatment Market Size (2015-2020)
6.2 Chronic Lymphocytic Leukemia Treatment Key Players in North America (2019-2020)
6.3 North America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020)
6.4 North America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chronic Lymphocytic Leukemia Treatment Market Size (2015-2020)
7.2 Chronic Lymphocytic Leukemia Treatment Key Players in Europe (2019-2020)
7.3 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020)
7.4 Europe Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
8 China
8.1 China Chronic Lymphocytic Leukemia Treatment Market Size (2015-2020)
8.2 Chronic Lymphocytic Leukemia Treatment Key Players in China (2019-2020)
8.3 China Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020)
8.4 China Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chronic Lymphocytic Leukemia Treatment Market Size (2015-2020)
9.2 Chronic Lymphocytic Leukemia Treatment Key Players in Japan (2019-2020)
9.3 Japan Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020)
9.4 Japan Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Size (2015-2020)
10.2 Chronic Lymphocytic Leukemia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
11 India
11.1 India Chronic Lymphocytic Leukemia Treatment Market Size (2015-2020)
11.2 Chronic Lymphocytic Leukemia Treatment Key Players in India (2019-2020)
11.3 India Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020)
11.4 India Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chronic Lymphocytic Leukemia Treatment Market Size (2015-2020)
12.2 Chronic Lymphocytic Leukemia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 4SC
13.1.1 4SC Company Details
13.1.2 4SC Business Overview
13.1.3 4SC Chronic Lymphocytic Leukemia Treatment Introduction
13.1.4 4SC Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020))
13.1.5 4SC Recent Development
13.2 AbbVie
13.2.1 AbbVie Company Details
13.2.2 AbbVie Business Overview
13.2.3 AbbVie Chronic Lymphocytic Leukemia Treatment Introduction
13.2.4 AbbVie Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.2.5 AbbVie Recent Development
13.3 ACEA Biosciences
13.3.1 ACEA Biosciences Company Details
13.3.2 ACEA Biosciences Business Overview
13.3.3 ACEA Biosciences Chronic Lymphocytic Leukemia Treatment Introduction
13.3.4 ACEA Biosciences Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.3.5 ACEA Biosciences Recent Development
13.4 ADC Therapeutics
13.4.1 ADC Therapeutics Company Details
13.4.2 ADC Therapeutics Business Overview
13.4.3 ADC Therapeutics Chronic Lymphocytic Leukemia Treatment Introduction
13.4.4 ADC Therapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.4.5 ADC Therapeutics Recent Development
13.5 Aeglea BioTherapeutics
13.5.1 Aeglea BioTherapeutics Company Details
13.5.2 Aeglea BioTherapeutics Business Overview
13.5.3 Aeglea BioTherapeutics Chronic Lymphocytic Leukemia Treatment Introduction
13.5.4 Aeglea BioTherapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.5.5 Aeglea BioTherapeutics Recent Development
13.6 Altor BioScience
13.6.1 Altor BioScience Company Details
13.6.2 Altor BioScience Business Overview
13.6.3 Altor BioScience Chronic Lymphocytic Leukemia Treatment Introduction
13.6.4 Altor BioScience Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.6.5 Altor BioScience Recent Development
13.7 Amgen
13.7.1 Amgen Company Details
13.7.2 Amgen Business Overview
13.7.3 Amgen Chronic Lymphocytic Leukemia Treatment Introduction
13.7.4 Amgen Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.7.5 Amgen Recent Development
13.8 Aptevo Therapeutics
13.8.1 Aptevo Therapeutics Company Details
13.8.2 Aptevo Therapeutics Business Overview
13.8.3 Aptevo Therapeutics Chronic Lymphocytic Leukemia Treatment Introduction
13.8.4 Aptevo Therapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.8.5 Aptevo Therapeutics Recent Development
13.9 ArQule
13.9.1 ArQule Company Details
13.9.2 ArQule Business Overview
13.9.3 ArQule Chronic Lymphocytic Leukemia Treatment Introduction
13.9.4 ArQule Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.9.5 ArQule Recent Development
13.10 Asana BioSciences
13.10.1 Asana BioSciences Company Details
13.10.2 Asana BioSciences Business Overview
13.10.3 Asana BioSciences Chronic Lymphocytic Leukemia Treatment Introduction
13.10.4 Asana BioSciences Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
13.10.5 Asana BioSciences Recent Development
13.11 Astellas Pharma
10.11.1 Astellas Pharma Company Details
10.11.2 Astellas Pharma Business Overview
10.11.3 Astellas Pharma Chronic Lymphocytic Leukemia Treatment Introduction
10.11.4 Astellas Pharma Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.11.5 Astellas Pharma Recent Development
13.12 Astex Pharmaceuticals
10.12.1 Astex Pharmaceuticals Company Details
10.12.2 Astex Pharmaceuticals Business Overview
10.12.3 Astex Pharmaceuticals Chronic Lymphocytic Leukemia Treatment Introduction
10.12.4 Astex Pharmaceuticals Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.12.5 Astex Pharmaceuticals Recent Development
13.13 AstraZeneca
10.13.1 AstraZeneca Company Details
10.13.2 AstraZeneca Business Overview
10.13.3 AstraZeneca Chronic Lymphocytic Leukemia Treatment Introduction
10.13.4 AstraZeneca Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.13.5 AstraZeneca Recent Development
13.14 Baliopharm
10.14.1 Baliopharm Company Details
10.14.2 Baliopharm Business Overview
10.14.3 Baliopharm Chronic Lymphocytic Leukemia Treatment Introduction
10.14.4 Baliopharm Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.14.5 Baliopharm Recent Development
13.15 Bayer
10.15.1 Bayer Company Details
10.15.2 Bayer Business Overview
10.15.3 Bayer Chronic Lymphocytic Leukemia Treatment Introduction
10.15.4 Bayer Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.15.5 Bayer Recent Development
13.16 BeiGene
10.16.1 BeiGene Company Details
10.16.2 BeiGene Business Overview
10.16.3 BeiGene Chronic Lymphocytic Leukemia Treatment Introduction
10.16.4 BeiGene Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.16.5 BeiGene Recent Development
13.17 Bellicum Pharmaceuticals
10.17.1 Bellicum Pharmaceuticals Company Details
10.17.2 Bellicum Pharmaceuticals Business Overview
10.17.3 Bellicum Pharmaceuticals Chronic Lymphocytic Leukemia Treatment Introduction
10.17.4 Bellicum Pharmaceuticals Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.17.5 Bellicum Pharmaceuticals Recent Development
13.18 Biogen
10.18.1 Biogen Company Details
10.18.2 Biogen Business Overview
10.18.3 Biogen Chronic Lymphocytic Leukemia Treatment Introduction
10.18.4 Biogen Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.18.5 Biogen Recent Development
13.19 Bionomics
10.19.1 Bionomics Company Details
10.19.2 Bionomics Business Overview
10.19.3 Bionomics Chronic Lymphocytic Leukemia Treatment Introduction
10.19.4 Bionomics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.19.5 Bionomics Recent Development
13.20 Biothera Pharmaceutical
10.20.1 Biothera Pharmaceutical Company Details
10.20.2 Biothera Pharmaceutical Business Overview
10.20.3 Biothera Pharmaceutical Chronic Lymphocytic Leukemia Treatment Introduction
10.20.4 Biothera Pharmaceutical Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020)
10.20.5 Biothera Pharmaceutical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Chronic Lymphocytic Leukemia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Lymphocytic Leukemia Treatment Revenue
Table 3. Ranking of Global Top Chronic Lymphocytic Leukemia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Lymphocytic Leukemia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Biological Therapy
Table 7. Key Players of Others
Table 8. Global Chronic Lymphocytic Leukemia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Chronic Lymphocytic Leukemia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Chronic Lymphocytic Leukemia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2015-2020)
Table 12. Global Chronic Lymphocytic Leukemia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Chronic Lymphocytic Leukemia Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Chronic Lymphocytic Leukemia Treatment Players
Table 19. Global Chronic Lymphocytic Leukemia Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Chronic Lymphocytic Leukemia Treatment Market Share by Players (2015-2020)
Table 21. Global Top Chronic Lymphocytic Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lymphocytic Leukemia Treatment as of 2019)
Table 22. Global Chronic Lymphocytic Leukemia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Chronic Lymphocytic Leukemia Treatment Product Solution and Service
Table 25. Date of Enter into Chronic Lymphocytic Leukemia Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Chronic Lymphocytic Leukemia Treatment Market Size Share by Type (2015-2020)
Table 29. Global Chronic Lymphocytic Leukemia Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Chronic Lymphocytic Leukemia Treatment Market Size Share by Application (2015-2020)
Table 31. Global Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Chronic Lymphocytic Leukemia Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Chronic Lymphocytic Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Chronic Lymphocytic Leukemia Treatment Market Share (2019-2020)
Table 35. North America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Chronic Lymphocytic Leukemia Treatment Market Share by Type (2015-2020)
Table 37. North America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Chronic Lymphocytic Leukemia Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Chronic Lymphocytic Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Chronic Lymphocytic Leukemia Treatment Market Share (2019-2020)
Table 41. Europe Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Chronic Lymphocytic Leukemia Treatment Market Share by Type (2015-2020)
Table 43. Europe Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Chronic Lymphocytic Leukemia Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Chronic Lymphocytic Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Chronic Lymphocytic Leukemia Treatment Market Share (2019-2020)
Table 47. China Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Chronic Lymphocytic Leukemia Treatment Market Share by Type (2015-2020)
Table 49. China Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Chronic Lymphocytic Leukemia Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Chronic Lymphocytic Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Chronic Lymphocytic Leukemia Treatment Market Share (2019-2020)
Table 53. Japan Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Chronic Lymphocytic Leukemia Treatment Market Share by Type (2015-2020)
Table 55. Japan Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Chronic Lymphocytic Leukemia Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Chronic Lymphocytic Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Chronic Lymphocytic Leukemia Treatment Market Share (2019-2020)
Table 59. Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Chronic Lymphocytic Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Chronic Lymphocytic Leukemia Treatment Market Share (2019-2020)
Table 65. India Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Chronic Lymphocytic Leukemia Treatment Market Share by Type (2015-2020)
Table 67. India Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Chronic Lymphocytic Leukemia Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Chronic Lymphocytic Leukemia Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Chronic Lymphocytic Leukemia Treatment Market Share (2019-2020)
Table 71. Central & South America Chronic Lymphocytic Leukemia Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Chronic Lymphocytic Leukemia Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Chronic Lymphocytic Leukemia Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Chronic Lymphocytic Leukemia Treatment Market Share by Application (2015-2020)
Table 75. 4SC Company Details
Table 76. 4SC Business Overview
Table 77. 4SC Product
Table 78. 4SC Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 79. 4SC Recent Development
Table 80. AbbVie Company Details
Table 81. AbbVie Business Overview
Table 82. AbbVie Product
Table 83. AbbVie Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 84. AbbVie Recent Development
Table 85. ACEA Biosciences Company Details
Table 86. ACEA Biosciences Business Overview
Table 87. ACEA Biosciences Product
Table 88. ACEA Biosciences Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 89. ACEA Biosciences Recent Development
Table 90. ADC Therapeutics Company Details
Table 91. ADC Therapeutics Business Overview
Table 92. ADC Therapeutics Product
Table 93. ADC Therapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 94. ADC Therapeutics Recent Development
Table 95. Aeglea BioTherapeutics Company Details
Table 96. Aeglea BioTherapeutics Business Overview
Table 97. Aeglea BioTherapeutics Product
Table 98. Aeglea BioTherapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 99. Aeglea BioTherapeutics Recent Development
Table 100. Altor BioScience Company Details
Table 101. Altor BioScience Business Overview
Table 102. Altor BioScience Product
Table 103. Altor BioScience Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 104. Altor BioScience Recent Development
Table 105. Amgen Company Details
Table 106. Amgen Business Overview
Table 107. Amgen Product
Table 108. Amgen Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 109. Amgen Recent Development
Table 110. Aptevo Therapeutics Business Overview
Table 111. Aptevo Therapeutics Product
Table 112. Aptevo Therapeutics Company Details
Table 113. Aptevo Therapeutics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 114. Aptevo Therapeutics Recent Development
Table 115. ArQule Company Details
Table 116. ArQule Business Overview
Table 117. ArQule Product
Table 118. ArQule Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 119. ArQule Recent Development
Table 120. Asana BioSciences Company Details
Table 121. Asana BioSciences Business Overview
Table 122. Asana BioSciences Product
Table 123. Asana BioSciences Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 124. Asana BioSciences Recent Development
Table 125. Astellas Pharma Company Details
Table 126. Astellas Pharma Business Overview
Table 127. Astellas Pharma Product
Table 128. Astellas Pharma Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 129. Astellas Pharma Recent Development
Table 130. Astex Pharmaceuticals Company Details
Table 131. Astex Pharmaceuticals Business Overview
Table 132. Astex Pharmaceuticals Product
Table 133. Astex Pharmaceuticals Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 134. Astex Pharmaceuticals Recent Development
Table 135. AstraZeneca Company Details
Table 136. AstraZeneca Business Overview
Table 137. AstraZeneca Product
Table 138. AstraZeneca Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 139. AstraZeneca Recent Development
Table 140. Baliopharm Company Details
Table 141. Baliopharm Business Overview
Table 142. Baliopharm Product
Table 143. Baliopharm Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 144. Baliopharm Recent Development
Table 145. Bayer Company Details
Table 146. Bayer Business Overview
Table 147. Bayer Product
Table 148. Bayer Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 149. Bayer Recent Development
Table 150. BeiGene Company Details
Table 151. BeiGene Business Overview
Table 152. BeiGene Product
Table 153. BeiGene Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 154. BeiGene Recent Development
Table 155. Bellicum Pharmaceuticals Company Details
Table 156. Bellicum Pharmaceuticals Business Overview
Table 157. Bellicum Pharmaceuticals Product
Table 158. Bellicum Pharmaceuticals Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 159. Bellicum Pharmaceuticals Recent Development
Table 160. Biogen Company Details
Table 161. Biogen Business Overview
Table 162. Biogen Product
Table 163. Biogen Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 164. Biogen Recent Development
Table 165. Bionomics Company Details
Table 166. Bionomics Business Overview
Table 167. Bionomics Product
Table 168. Bionomics Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 169. Bionomics Recent Development
Table 170. Biothera Pharmaceutical Company Details
Table 171. Biothera Pharmaceutical Business Overview
Table 172. Biothera Pharmaceutical Product
Table 173. Biothera Pharmaceutical Revenue in Chronic Lymphocytic Leukemia Treatment Business (2015-2020) (Million US$)
Table 174. Biothera Pharmaceutical Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Lymphocytic Leukemia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Biological Therapy Features
Figure 4. Others Features
Figure 5. Global Chronic Lymphocytic Leukemia Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Chronic Lymphocytic Leukemia Treatment Report Years Considered
Figure 10. Global Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Chronic Lymphocytic Leukemia Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Chronic Lymphocytic Leukemia Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Chronic Lymphocytic Leukemia Treatment Market Share by Players in 2019
Figure 15. Global Top Chronic Lymphocytic Leukemia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lymphocytic Leukemia Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Chronic Lymphocytic Leukemia Treatment Revenue in 2019
Figure 17. North America Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Chronic Lymphocytic Leukemia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
慢性リンパ性白血病（CLL）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market size is projected to reach US$ 9390.9 million by 2026, from US$ 8411.2 million in 2020, at a CAGR of 10.8%% during 2021-2026. Global Chronic Lymphocytic L…- B細胞慢性リンパ球性白血病治療の世界市場（～2026年） Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global B-Cell Chronic Lymphocy…
- 慢性骨髄性白血病治療の世界市場（～2026年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…
- 白血病の世界市場（～2026年） Leukemia is a group ofcancers that usually begin in the bone marrow and result in high numbers of abnormal white blood cells. High incidence rate of blood cancers and rise in incidence of leukaemia across the globe will drive the leukemia market. Market Analysis and Insights: Global Leukemia Cancer …
- 白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…